ZSCAN22
gene geneOn this page
Summary
ZSCAN22 (zinc finger and SCAN domain containing 22, HGNC:4929) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger and SCAN domain-containing protein 22 (P10073). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 342945 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 80 total
- MANE Select transcript:
NM_181846
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4929 |
| Approved symbol | ZSCAN22 |
| Name | zinc finger and SCAN domain containing 22 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182318 |
| Ensembl biotype | protein_coding |
| OMIM | 165260 |
| Entrez | 342945 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000329665, ENST00000850584, ENST00000904370, ENST00000904371, ENST00000904372, ENST00000904373, ENST00000904374
RefSeq mRNA: 3 — MANE Select: NM_181846
NM_001321116, NM_001321117, NM_181846
CCDS: CCDS12975
Canonical transcript exons
ENST00000329665 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001333334 | 58334752 | 58335205 |
| ENSE00001333335 | 58326994 | 58327114 |
| ENSE00002284614 | 58338254 | 58342332 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 82.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2776 / max 135.8130, expressed in 1552 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177828 | 2.8841 | 1475 |
| 208953 | 0.3935 | 186 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.64 | gold quality |
| ileal mucosa | UBERON:0000331 | 77.71 | gold quality |
| tibialis anterior | UBERON:0001385 | 76.64 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.39 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.61 | gold quality |
| cerebellar vermis | UBERON:0004720 | 71.33 | gold quality |
| pancreatic ductal cell | CL:0002079 | 70.88 | silver quality |
| granulocyte | CL:0000094 | 69.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.89 | gold quality |
| cortical plate | UBERON:0005343 | 68.88 | gold quality |
| upper arm skin | UBERON:0004263 | 68.61 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.17 | gold quality |
| deltoid | UBERON:0001476 | 66.89 | silver quality |
| right lobe of liver | UBERON:0001114 | 66.38 | gold quality |
| ventricular zone | UBERON:0003053 | 66.20 | gold quality |
| cerebellar cortex | UBERON:0002129 | 65.96 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 65.87 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 65.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 65.51 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.46 | gold quality |
| right adrenal gland | UBERON:0001233 | 65.25 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 65.20 | gold quality |
| pituitary gland | UBERON:0000007 | 65.15 | gold quality |
| skin of leg | UBERON:0001511 | 65.05 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 64.99 | gold quality |
| adenohypophysis | UBERON:0002196 | 64.96 | gold quality |
| left adrenal gland | UBERON:0001234 | 64.82 | gold quality |
| cerebellum | UBERON:0002037 | 64.80 | gold quality |
| right coronary artery | UBERON:0001625 | 64.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
96 targeting ZSCAN22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-9718 | 99.94 | 68.91 | 918 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-5002-5P | 99.76 | 70.84 | 1763 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zscan22 | ENSMUSG00000054715 |
| rattus_norvegicus | Zscan22 | ENSRNOG00000031113 |
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger and SCAN domain-containing protein 22 — P10073 (reviewed: P10073)
Alternative names: Krueppel-related zinc finger protein 2, Protein HKR2, Zinc finger protein 50
All UniProt accessions (1): P10073
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001308045, NP_001308046, NP_862829* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
Pfam: PF00096, PF02023
UniProt features (16 total): zinc finger region 8, region of interest 2, compositionally biased region 2, chain 1, domain 1, modified residue 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P10073-F1 | 69.05 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 9, 443
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GTGCCTT_MIR506, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, RB_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FEV_TARGET_GENES, H1_6_TARGET_GENES, HES4_TARGET_GENES, NFE2L1_TARGET_GENES, SALL4_TARGET_GENES, TEAD2_TARGET_GENES, ZNF766_TARGET_GENES, ZNF8_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
570 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZSCAN22 | MYCL | P12524 | 498 |
| ZSCAN22 | MYCN | P04198 | 431 |
| ZSCAN22 | PRR19 | A6NJB7 | 418 |
| ZSCAN22 | ZSCAN21 | Q9Y5A6 | 396 |
| ZSCAN22 | NRAS | P01111 | 390 |
| ZSCAN22 | CCDC97 | Q96F63 | 370 |
| ZSCAN22 | ZSWIM5 | Q9P217 | 348 |
| ZSCAN22 | A0A0A6YYG8 | A0A0A6YYG8 | 336 |
| ZSCAN22 | ERBB2 | P04626 | 323 |
| ZSCAN22 | FAM8A1 | Q9UBU6 | 315 |
| ZSCAN22 | ZNF750 | Q32MQ0 | 311 |
| ZSCAN22 | EGFR | P00533 | 311 |
| ZSCAN22 | APOE | P02649 | 305 |
| ZSCAN22 | ALDH16A1 | Q8IZ83 | 296 |
| ZSCAN22 | ZBTB48 | P10074 | 289 |
IntAct
156 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZSCAN22 | ZSCAN32 | psi-mi:“MI:0915”(physical association) | 0.800 |
| ZSCAN32 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.800 |
| PGBD1 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.790 |
| ZSCAN22 | PGBD1 | psi-mi:“MI:0915”(physical association) | 0.790 |
| ZSCAN22 | ZNF496 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF496 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZSCAN22 | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.760 |
| ZSCAN22 | ZNF446 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF446 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF483 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN22 | ZNF483 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (46): ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Affinity Capture-MS), ZSCAN22 (Affinity Capture-MS), ZSCAN22 (Two-hybrid), SCAND1 (Affinity Capture-MS), ZSCAN22 (Affinity Capture-MS), ZSCAN22 (Affinity Capture-MS), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid), ZSCAN22 (Two-hybrid)
ESM2 similar proteins: A0A0J9YX57, A1A5P9, A2A368, A2A9R3, A8MXT2, B2KFW1, O15479, O15480, O15481, O15553, P0C6Y7, P10073, P17040, P25233, P43355, P43356, P43357, P43358, P43360, P43362, P43363, P43364, P43366, Q13342, Q16666, Q4R998, Q5PPP4, Q5RD14, Q6AY37, Q6PCZ4, Q8BQR7, Q8IWY8, Q8IX06, Q8N660, Q8N7X4, Q8TD90, Q96DU7, Q96LZ2, Q96M61, Q99608
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
792 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58327444:G:GG | donor_gain | 0.9800 |
| 19:58327514:A:G | donor_gain | 0.9800 |
| 19:58335201:GAGAG:G | donor_gain | 0.9800 |
| 19:58327441:G:GT | donor_gain | 0.9700 |
| 19:58327507:A:G | donor_gain | 0.9700 |
| 19:58335203:GAG:G | donor_gain | 0.9700 |
| 19:58335267:G:GT | donor_gain | 0.9700 |
| 19:58334748:GC:G | acceptor_loss | 0.9600 |
| 19:58334749:CAG:C | acceptor_loss | 0.9600 |
| 19:58334751:G:GC | acceptor_loss | 0.9600 |
| 19:58335157:G:GT | donor_gain | 0.9600 |
| 19:58327485:G:GT | donor_gain | 0.9500 |
| 19:58334750:A:AG | acceptor_gain | 0.9500 |
| 19:58334751:G:GG | acceptor_gain | 0.9500 |
| 19:58335202:AGAGG:A | donor_loss | 0.9500 |
| 19:58335204:AGG:A | donor_loss | 0.9500 |
| 19:58335205:GGTAA:G | donor_loss | 0.9500 |
| 19:58335207:T:G | donor_loss | 0.9500 |
| 19:58327521:G:GG | donor_gain | 0.9400 |
| 19:58327441:GGA:G | donor_gain | 0.9300 |
| 19:58327442:GAG:G | donor_gain | 0.9300 |
| 19:58327443:A:T | donor_gain | 0.9300 |
| 19:58335208:A:T | donor_loss | 0.9200 |
| 19:58335260:G:GT | donor_gain | 0.9100 |
| 19:58327400:C:CG | donor_gain | 0.9000 |
| 19:58327442:GA:G | donor_gain | 0.9000 |
| 19:58327454:G:GT | donor_gain | 0.9000 |
| 19:58334751:GGCCC:G | acceptor_gain | 0.9000 |
| 19:58335496:G:GG | donor_gain | 0.9000 |
| 19:58327449:T:A | donor_gain | 0.8900 |
AlphaMissense
3212 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58338763:T:C | F305L | 0.999 |
| 19:58338765:C:A | F305L | 0.999 |
| 19:58338765:C:G | F305L | 0.999 |
| 19:58338847:T:C | F333L | 0.999 |
| 19:58338849:C:A | F333L | 0.999 |
| 19:58338849:C:G | F333L | 0.999 |
| 19:58338931:T:C | F361L | 0.999 |
| 19:58338933:C:A | F361L | 0.999 |
| 19:58338933:C:G | F361L | 0.999 |
| 19:58339015:T:C | F389L | 0.999 |
| 19:58339017:C:A | F389L | 0.999 |
| 19:58339017:C:G | F389L | 0.999 |
| 19:58339099:T:C | F417L | 0.999 |
| 19:58339101:C:A | F417L | 0.999 |
| 19:58339101:C:G | F417L | 0.999 |
| 19:58339183:T:C | F445L | 0.999 |
| 19:58339185:T:A | F445L | 0.999 |
| 19:58339185:T:G | F445L | 0.999 |
| 19:58339267:T:C | F473L | 0.999 |
| 19:58339269:C:A | F473L | 0.999 |
| 19:58339269:C:G | F473L | 0.999 |
| 19:58338876:C:A | H342Q | 0.998 |
| 19:58338876:C:G | H342Q | 0.998 |
| 19:58338874:C:G | H342D | 0.997 |
| 19:58338888:T:A | H346Q | 0.997 |
| 19:58338888:T:G | H346Q | 0.997 |
| 19:58338950:T:C | L367P | 0.997 |
| 19:58338960:C:A | H370Q | 0.997 |
| 19:58338960:C:G | H370Q | 0.997 |
| 19:58339034:T:C | L395P | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000381162 (19:58337363 C>G,T), RS1000409987 (19:58330498 T>A), RS1000698980 (19:58334933 A>T), RS1000958073 (19:58341124 A>G), RS1001178283 (19:58338663 C>T), RS1001407962 (19:58332161 G>A), RS1001465545 (19:58325761 T>G), RS1001695362 (19:58332035 G>A), RS1002216867 (19:58339950 C>T), RS1002238907 (19:58331513 C>T), RS1002291474 (19:58333546 A>T), RS1002467957 (19:58327051 G>A,C,T), RS1002471045 (19:58338382 T>C), RS1002818136 (19:58333796 T>C,G), RS1002852298 (19:58337020 T>C)
Disease associations
OMIM: gene MIM:165260 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | increases expression | 1 |
| urushiol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Sunitinib | decreases expression | 1 |
| Benzene | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lithium Chloride | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.